Cocrystal Pharma earnings were -$15.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest COCP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.3M, down 29.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, COCP reported annual earnings of -$17.5M, with -2.7% growth.
What were Cocrystal Pharma's earnings last quarter?
On COCP's earnings call on Invalid Date, Cocrystal Pharma (NASDAQ: COCP) reported Q1 2025 earnings per share (EPS) of -$0.23, up 41.03% year over year. Total COCP earnings for the quarter were -$2.30 million. In the same quarter last year, Cocrystal Pharma's earnings per share (EPS) was -$0.39.
As of the last Cocrystal Pharma earnings report, Cocrystal Pharma is currently losing money. Cocrystal Pharma's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$15.85 million, a 5.38% decrease year over year.
What was COCP's earnings growth in the past year?
As of Cocrystal Pharma's earnings date in Invalid Date, Cocrystal Pharma's earnings has grown year over year. COCP earnings in the past year totalled -$15.85 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.